NRX Pharmaceuticals Inc./$NRXP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Ticker
$NRXP
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
-
ISIN
US6294442099
Website
NRXP Metrics
BasicAdvanced
$57M
-
-$1.92
1.55
-
Price and volume
Market cap
$57M
Beta
1.55
52-week high
$3.28
52-week low
$1.58
Average daily volume
312K
Financial strength
Current ratio
0.222
Quick ratio
0.169
Total debt to equity
-33.373
Management effectiveness
Return on assets (TTM)
-191.74%
Return on equity (TTM)
119.86%
Valuation
Price to book
-2.22
Price to tangible book (TTM)
-2.22
Price to free cash flow (TTM)
-3.924
Growth
Earnings per share change (TTM)
-39.05%
3-year earnings per share growth (CAGR)
-68.66%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for NRX Pharmaceuticals Inc. stock?
NRX Pharmaceuticals Inc. (NRXP) has a market cap of $57M as of June 09, 2025.
What is the P/E ratio for NRX Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for NRX Pharmaceuticals Inc. (NRXP) stock is 0 as of June 09, 2025.
Does NRX Pharmaceuticals Inc. stock pay dividends?
No, NRX Pharmaceuticals Inc. (NRXP) stock does not pay dividends to its shareholders as of June 09, 2025.
When is the next NRX Pharmaceuticals Inc. dividend payment date?
NRX Pharmaceuticals Inc. (NRXP) stock does not pay dividends to its shareholders.
What is the beta indicator for NRX Pharmaceuticals Inc.?
NRX Pharmaceuticals Inc. (NRXP) has a beta rating of 1.55. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.